Fisher & Paykel Healthcare's stock soared 6.19% during intraday trading on Monday, reflecting strong investor sentiment.
The surge follows the company's announcement that it now expects operating revenue to be approximately NZ$2.30 billion and net profit after tax to be in the range of NZ$450 million to NZ$470 million for the fiscal year ending March 31. This upgraded guidance has boosted confidence in the company's financial performance.
Health technology stocks broadly gained on the exchange, with Fisher & Paykel Healthcare leading the sector's advance.